CAMELLIA: Anti-CD47 Antibody Therapy in Haematological Malignancies
NCT02678338
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Acute Myeloid Leukemia
Myelodysplastic Syndrome
Interventions
DRUG:
Hu5F9-G4
Sponsor
Gilead Sciences
Collaborators
[object Object]